Skip to main content
TipRanks
Go Ultimate75% OFF

Genetec Corp. (4492) AI Stock Analysis

0 Followers
JP:4492

Genetec Corp.

(TSE/TYO:4492)

Select Model
Rating:60.6Neutral
Price Target:JPY 304.00â–²(5.19% Upside)
Action:reiterated
Date:11/07/26

The overall score is weighed down significantly by extremely bearish technicals and poor cash flow generation, despite a fundamentally sound balance sheet and strong revenue growth. The very low P/E and high dividend yield provide a valuation cushion, but the primary drivers of the score are the severe technical downtrend and the cash flow red flag.

Positive Factors
Accelerating Revenue GrowthRevenue growth accelerated to about 28% in 2026 from 14% in 2025, indicating strengthening demand and improving scale. If sustained, this expansion can widen the company’s operating footprint and provide a durable base for reinvestment and future earnings growth.
Negative Factors
Higher LeverageThe substantial increase in debt relative to equity has reduced financial flexibility from the company’s historically low-debt profile. Higher leverage can constrain future investment choices, increase financing sensitivity, and make the business less able to absorb weaker operating conditions.

Genetec Corp. (4492) vs. iShares MSCI Japan ETF (EWJ)

-40%-30%-20%-10%0%10%20%30%JP:4492-31.98%EWJ+16.06%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 3.35B
Dividend Yield
6.57%
Average Volume (3M)
42.48K
Price to Earnings (P/E)
6.5
Beta (1Y)
0.76
Revenue Growth
28.33%
EPS Growth
27.93%
Country
Japan
Employees
648
Sector
General
Sector Strength
55
Industry
Software - Application

Genetec Corp. Business Overview & Revenue Model

Company Description

Genetec Corporation is a Japanese company specializing in software development. Its operations are structured across three main business segments: Digital Solutions, Engineering Solutions, and Cocodayo. The Digital Solutions division focuses on creat...

Genetec Corp. Financial Statement Overview

Summary

Strong revenue growth (+28%) and a healthy balance sheet (D/E 0.76, ROE 18.7%) are offset by a sharp decline in cash flow. Operating cash flow fell to just ¥113M (1% of revenue), indicating poor cash conversion and a potential red flag for sustainability.

Income Statement

70Positive

Balance Sheet

80Positive

Cash Flow

45Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue11.03B10.98B8.12B7.15B5.86B4.68B
Gross Profit4.18B4.15B3.27B2.91B2.32B1.96B
EBITDA1.07B1.06B849.75M775.92M259.62M226.31M
Net Income497.35M510.44M421.12M414.77M23.76M56.64M
Balance Sheet
Total Assets6.27B6.91B7.15B4.52B4.12B3.25B
Cash, Cash Equivalents and Short-Term Investments1.59B1.60B1.99B1.17B1.08B1.04B
Total Debt1.82B2.07B2.26B640.00M976.09M50.62M
Total Liabilities3.70B4.19B4.75B2.31B2.26B1.39B
Stockholders Equity2.57B2.73B2.40B2.21B1.87B1.86B
Cash Flow
Free Cash Flow046.85M384.76M578.85M-322.73M-117.29M
Operating Cash Flow0112.60M451.42M602.37M-223.12M-24.03M
Investing Cash Flow0-47.84M-388.73M-55.73M-439.20M-98.15M
Financing Cash Flow0-398.87M655.92M-410.02M714.93M-94.71M

Genetec Corp. Technical Analysis

Technical Analysis SentimentNegative
Last Price289.00

Price Trends

50DMA370.20Negative
100DMA381.71Negative
200DMA410.34Negative

Market Momentum

MACD-26.06Positive
RSI29.21Positive
STOCH32.20Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4492, the sentiment is Negative. The current price of 289.00 is below the 20-day moving average (MA) of 340.95, below the 50-day MA of 370.20, and below the 200-day MA of 410.34, indicating a bearish trend. The MACD of -26.06 indicates Positive momentum. The RSI at 29.21 is Positive, neither overbought nor oversold. The STOCH value of 32.20 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4492.

Genetec Corp. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:4492 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:3826JP:382679OutperformJPY 5.29B11.58―2.71%13.99%-36.97%
JP:4491JP:449175OutperformJPY 5.68B10.33―2.16%7.70%32.16%
JP:4492JP:449261NeutralJPY 3.35B6.54―6.57%28.33%27.93%
JP:4397JP:439760NeutralJPY 5.75B15.22――23.50%2.72%
JP:5033JP:503359NeutralJPY 7.75B47.28――7.04%-67.36%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
JP:7527JP:752751NeutralJPY 4.76B80.36――16.20%―

* General Sector Average

Performance Comparison

-25%0%25%50%JP:4492JP:3826JP:4397JP:4491JP:5033JP:7527Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:4492 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:4492Genetec Corp.289.00-139.70-32.59%
JP:3826System Integrator Corp.480.0036.668.27%
JP:4397TeamSpirit, Inc.348.00-162.00-31.76%
JP:4491Computer Management Co., Ltd.2780.00217.308.48%
JP:5033Nulab Inc.1195.00430.0056.21%
JP:7527SystemSoft Corporation45.00-25.00-35.71%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 07, 2026